NEW YORK (GenomeWeb) – After falling 3 percent in 2016 in what was a dismal year for biotechnology stocks, the GenomeWeb Index surged 39 percent in 2017, led by nearly three-fold gains in the stock prices of Exact Sciences and Foundation Medicine.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.